CAP Changemakers: Pathway to the ACA VideoApr 17, 2024 CAP Changemakers: Pathway to the ACA This conversation with Emily Gee and Karen Davenport, highlights CAP's role in the development of the Affordable Care Act. Apr 17, 2024 Emily Gee, Karen Davenport, Toni Pandolfo, 3 More Olivia Mowry, Hai-Lam Phan, Matthew Gossage
Monthly Medicare Drug Price Negotiation Savings by State InteractiveApr 2, 2024 Monthly Medicare Drug Price Negotiation Savings by State Medicare drug price negotiation will result in thousands of dollars in net price savings for 30-day supplies of the first 10 drugs undergoing negotiation; here’s how those savings add up state by state. Apr 2, 2024 Nicole Rapfogel
5 Things To Know About Pharmacy Benefit Managers ArticleMar 13, 2024 5 Things To Know About Pharmacy Benefit Managers Pharmacy benefit managers are pharmaceutical middlemen that can inflate prescription drug costs for insurers and consumers. Mar 13, 2024 Nicole Rapfogel
Medicare Drug Price Negotiation Will Lower Prices by Thousands of Dollars per Month ArticleFeb 21, 2024 Medicare Drug Price Negotiation Will Lower Prices by Thousands of Dollars per Month A new analysis estimates prices for 30-day supplies of the first 10 Medicare Part D drugs undergoing price negotiations, with monthly reductions as high as $6,500 for some drugs. Feb 21, 2024 Nicole Rapfogel
Federal Solutions To Address Rising Costs of Employer-Sponsored Insurance ReportJan 25, 2024 Federal Solutions To Address Rising Costs of Employer-Sponsored Insurance Federal policymakers should act to lower health insurance costs and improve affordability for both employers and workers. Jan 25, 2024 Sam Hughes, Nicole Rapfogel, Emily Gee
CAP Files Amicus Curiae Briefs Highlighting Importance of the Inflation Reduction Act in Lowering Drug Prices ArticleJan 23, 2024 CAP Files Amicus Curiae Briefs Highlighting Importance of the Inflation Reduction Act in Lowering Drug Prices These briefs emphasize the benefits of the Inflation Reduction Act’s Medicare prescription drug price negotiation program for affordability and health equity. Jan 23, 2024 Sophia Weaver, Marquisha Johns, Andrea Ducas, 3 More Jamie Crooks, Devon Ombres, Ben Olinsky
CAP Files Amicus Curiae Brief Highlighting Importance of the Inflation Reduction Act in Lowering Drug Prices ArticleDec 22, 2023 CAP Files Amicus Curiae Brief Highlighting Importance of the Inflation Reduction Act in Lowering Drug Prices This brief, filed by the Center for American Progress and the NAACP in response to Boehringer Ingelheim Pharmaceuticals Inc. v. U.S. Department of Health and Human Services et al., emphasizes the benefits of the Inflation Reduction Act’s Medicare prescription drug price negotiation program for affordability and health equity. Dec 22, 2023 Sophia Weaver, Marquisha Johns, Andrea Ducas
Drug Companies Continue To Hike Prices Above Inflation ArticleNov 1, 2023 Drug Companies Continue To Hike Prices Above Inflation New analysis makes clear that the Inflation Reduction Act’s inflation rebates should extend to the commercial market. Nov 1, 2023 Nicole Rapfogel
Putting Health Over Profit: How Pharma Can Make Medicine More Affordable for Women ArticleOct 16, 2023 Putting Health Over Profit: How Pharma Can Make Medicine More Affordable for Women Drug companies must prioritize access to and set affordable prices for birth control and drugs that treat postpartum depression. Oct 16, 2023 Kierra B. Jones
Following the Money: Untangling U.S. Prescription Drug Financing ReportOct 12, 2023 Following the Money: Untangling U.S. Prescription Drug Financing This report discusses how money flows through the pharmaceutical ecosystem and how policymakers should address high prices. Oct 12, 2023 Sam Hughes, Nicole Rapfogel
5 Facts To Know About Medicare Drug Price Negotiation ArticleAug 30, 2023 5 Facts To Know About Medicare Drug Price Negotiation Price negotiation will improve access and affordability for Medicare Part D drugs for seniors. Aug 30, 2023 Nicole Rapfogel
In the face of a national drug shortage, the US must bolster its supply chains In the NewsAug 27, 2023 In the face of a national drug shortage, the US must bolster its supply chains Marquisha Johns writes in The Hill why reauthorizing the Pandemic and All-Hazards Preparedness and Response Act is essential to avoid drug supply chain issues and shortages. Aug 27, 2023 The Hill Marquisha Johns
Strengthening Health Strengthening Health We work to strengthen public health systems and improve health care coverage, access, and affordability.